Philips (NYSE: PHG)+
announced today that it received FDA clearance for its latest pathology solution, the IntelliSite Pathology Solution 5.1.

Oticon Medical announced today that the FDA granted clearance for its Sentio transcutaneous bone conduction hearing system.